Evelyne Dietrich
Aegera Therapeutics (Canada)(CA)
Publications by Year
Research Areas
Antimicrobial Resistance in Staphylococcus, Hepatitis C virus research, HIV/AIDS drug development and treatment, Orthopedic Infections and Treatments, Cancer therapeutics and mechanisms
Most-Cited Works
- → CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition(2022)203 cited
- → Oritavancin Exhibits Dual Mode of Action to Inhibit Cell-Wall Biosynthesis in Staphylococcus aureus(2008)130 cited
- → Vancomycin and Oritavancin Have Different Modes of Action in Enterococcus faecium(2009)79 cited
- → Linking Bisphosphonates to the Free Amino Groups in Fluoroquinolones: Preparation of Osteotropic Prodrugs for the Prevention of Osteomyelitis(2008)74 cited
- → Discovery of an Orally Bioavailable and Selective PKMYT1 Inhibitor, RP-6306(2022)65 cited
- → Bisphosphonated fluoroquinolone esters as osteotropic prodrugs for the prevention of osteomyelitis(2008)44 cited
- → A new class of small molecule RNA polymerase inhibitors with activity against Rifampicin-resistant Staphylococcus aureus(2006)40 cited
- → Locations of the Hydrophobic Side Chains of Lipoglycopeptides Bound to the Peptidoglycan of Staphylococcus aureus(2013)36 cited
- → Efficient Synthesis of Enantiopure Pyrrolizidinone Amino Acid(2003)32 cited
- → Synthesis and in vitro evaluation of bisphosphonated glycopeptide prodrugs for the treatment of osteomyelitis(2010)29 cited